Minoru Nishida

1.6k total citations
86 papers, 1.3k citations indexed

About

Minoru Nishida is a scholar working on Pharmacology, Molecular Medicine and Molecular Biology. According to data from OpenAlex, Minoru Nishida has authored 86 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pharmacology, 33 papers in Molecular Medicine and 25 papers in Molecular Biology. Recurrent topics in Minoru Nishida's work include Antibiotic Resistance in Bacteria (33 papers), Antibiotics Pharmacokinetics and Efficacy (33 papers) and Microbial Natural Products and Biosynthesis (11 papers). Minoru Nishida is often cited by papers focused on Antibiotic Resistance in Bacteria (33 papers), Antibiotics Pharmacokinetics and Efficacy (33 papers) and Microbial Natural Products and Biosynthesis (11 papers). Minoru Nishida collaborates with scholars based in Japan and United States. Minoru Nishida's co-authors include YASUHIRO MINE, Sachiko Gotô, Shōgo Kuwahara, Takeo Murakawa, T Matsubara, Yoshiko Yokota, Naoki Arizono, Atsufumi Kawabata, Hiroyuki Nishikawa and Hitoshi Kojo and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and Journal of Clinical Microbiology.

In The Last Decade

Minoru Nishida

84 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minoru Nishida Japan 21 454 373 277 210 173 86 1.3k
Jean‐Michel Bruneau France 15 204 0.4× 602 1.6× 191 0.7× 66 0.3× 162 0.9× 19 1.3k
JoAnn Hoskins United States 19 153 0.3× 723 1.9× 107 0.4× 306 1.5× 93 0.5× 23 1.5k
Martin Forbes United States 18 147 0.3× 392 1.1× 121 0.4× 83 0.4× 85 0.5× 42 1.2k
Y Osada Japan 23 625 1.4× 780 2.1× 403 1.5× 52 0.2× 252 1.5× 84 1.8k
J. Andrews United Kingdom 22 190 0.4× 675 1.8× 130 0.5× 145 0.7× 154 0.9× 56 1.6k
Joey Leung United States 11 126 0.3× 340 0.9× 87 0.3× 78 0.4× 254 1.5× 14 1.1k
Subhash Dhawan United States 22 103 0.2× 741 2.0× 143 0.5× 76 0.4× 564 3.3× 56 1.8k
Shigeo Morimoto Japan 23 209 0.5× 638 1.7× 113 0.4× 46 0.2× 61 0.4× 62 1.5k
A Oratore Italy 16 170 0.4× 429 1.2× 453 1.6× 27 0.1× 58 0.3× 83 985
Edwin M. Oden United States 17 492 1.1× 382 1.0× 215 0.8× 15 0.1× 64 0.4× 32 1.1k

Countries citing papers authored by Minoru Nishida

Since Specialization
Citations

This map shows the geographic impact of Minoru Nishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minoru Nishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minoru Nishida more than expected).

Fields of papers citing papers by Minoru Nishida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minoru Nishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minoru Nishida. The network helps show where Minoru Nishida may publish in the future.

Co-authorship network of co-authors of Minoru Nishida

This figure shows the co-authorship network connecting the top 25 collaborators of Minoru Nishida. A scholar is included among the top collaborators of Minoru Nishida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minoru Nishida. Minoru Nishida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishikawa, Hiroyuki, Kenzo Kawai, Makoto Tanaka, et al.. (2004). Protease-Activated Receptor-2 (PAR-2)-Related Peptides Induce Tear Secretion in Rats: Involvement of PAR-2 and Non-PAR-2 Mechanisms. Journal of Pharmacology and Experimental Therapeutics. 312(1). 324–331. 9 indexed citations
2.
Kobayashi, Intetsu, Akiko Kanayama, Takeshi Saika, et al.. (2003). Tendency toward increase in the frequency of isolation of β-lactamase-nonproducing Neisseria gonorrhoeae exhibiting penicillin resistance, and recent emergence of multidrug-resistant isolates in Japan. Journal of Infection and Chemotherapy. 9(2). 126–130. 1 indexed citations
3.
Nishida, Minoru, Kenzo Kawai, Makoto Tanaka, Tatsuya Tegoshi, & Naoki Arizono. (2003). Expression of E‐cadherin in human mast cell line HMC‐1. Apmis. 111(11). 1067–1074. 11 indexed citations
4.
Saika, Takeshi, et al.. (2002). Antimicrobial resistance and DNA-fingerprinting pattern of Burkholderia cepacia blood isolates. Journal of Infection and Chemotherapy. 8(4). 341–344. 6 indexed citations
5.
Kawabata, Atsufumi, Mitsuhiro Kinoshita, Hiroyuki Nishikawa, et al.. (2001). The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection. Journal of Clinical Investigation. 107(11). 1443–1450. 145 indexed citations
6.
Tegoshi, Tatsuya, Minoru Nishida, Kenji Ishiwata, et al.. (2000). E-Cadherin and Cadherin-Associated Cytoplasmic Proteins Are Expressed in Murine Mast Cells. Laboratory Investigation. 80(10). 1571–1581. 19 indexed citations
7.
Nishikawa, Hiroyuki, Atsufumi Kawabata, Ryotaro Kuroda, Minoru Nishida, & Kenzo Kawai. (2000). Characterization of Protease-Activated Receptors in Rat Peritoneal Mast Cells. The Japanese Journal of Pharmacology. 82(1). 74–77. 30 indexed citations
8.
Gotô, Sachiko, Akiyoshi Tsuji, Minoru Nishida, et al.. (1999). Present situation of serotyping of Pseudomonas aeruginosa in Japan and correlation among three kinds of commercially available serotyping kits. Journal of Infection and Chemotherapy. 5(4). 201–205. 3 indexed citations
9.
10.
Kobayashi, Intetsu, Hiroe Muraoka, Takeshi Saika, et al.. (1998). A mouse model of Escherichia coli .O157: H7 infection for evaluation of antibacterial drugs - In vivo release of verotoxins and toxic effect on mice. 46(3). 112–118. 3 indexed citations
11.
12.
Uchikawa, Ryuichi, Shinji Matsuda, Minoru Yamada, et al.. (1997). Nematode infection induces Th2 cell‐associated immune responses in LEC mutant rats with helper T cell immunodeficiency. Parasite Immunology. 19(10). 461–468. 3 indexed citations
13.
Kobayashi, Intetsu, et al.. (1996). Drug susceptibility of Helicobacter pylori freshly isolated from gastrointestinal mucosa of patients with peptic ulcer.. Chemotherapy. 44(9). 719–722. 1 indexed citations
14.
Kobayashi, Intetsu, et al.. (1996). Drug-resistance Patterns of Clinical Isolates of Pseudomonas aeruginosa in Regard to Their Lipopolysaccharide-chain Sizes. Kansenshogaku zasshi. 70(6). 605–612. 1 indexed citations
15.
Aramori, Ichiro, Hitoshi Kojo, Minoru Nishida, Sachiko Gotô, & Shōgo Kuwahara. (1988). Role of the cephalosporinase gene in the resistance of the clinically isolated cephem-resistant Escherichia coli.. The Journal of Antibiotics. 41(1). 113–122. 3 indexed citations
16.
Kobayashi, Intetsu, Shuichi Miyazaki, Minoru Nishida, Sachiko Gotô, & Kaoru Takahashi. (1986). Haemolytic and protease activities and drug susceptibility of enterococcus faecalis and other d group streptococci from clinical specimens and normal intestinal flora. Chemotherapy. 34(12). 1238–1245. 1 indexed citations
17.
Ikeda, Fumiaki, et al.. (1983). Antagonism of cephem antibiotics and β-Lactamase induction in gram-negative bacilli. Chemotherapy. 31(3). 304–308. 2 indexed citations
18.
Kamimura, Toshiaki, et al.. (1980). In vitro and in vivo antibacterial activities of FR-31564, a new phosphonic acid antibiotic.. The Journal of Antibiotics. 33(1). 36–43. 38 indexed citations
19.
MINE, YASUHIRO, et al.. (1977). Nocardicin A, a new monocyclic .BETA.-lactam antibiotic. V. in vivo evaluation.: IN VIVO EVALUATION. The Journal of Antibiotics. 30(11). 932–937. 4 indexed citations
20.
Nishida, Minoru, et al.. (1977). NOCARDICIN A, A NEW MONOCYCLIC β-LACTAM ANTIBIOTIC. III. The Journal of Antibiotics. 30(11). 917–931. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Michel Bruneau Breakdown of academic impact, for papers by JoAnn Hoskins Breakdown of academic impact, for papers by Martin Forbes Breakdown of academic impact, for papers by Y Osada Breakdown of academic impact, for papers by J. Andrews Breakdown of academic impact, for papers by Joey Leung Breakdown of academic impact, for papers by Subhash Dhawan Breakdown of academic impact, for papers by Shigeo Morimoto Breakdown of academic impact, for papers by A Oratore Breakdown of academic impact, for papers by Edwin M. Oden
Rankless by CCL
2026